Safety and Efficacy Profile of Cyclin‐dependent Kinases 4/6 Inhibitor Palbociclib in Cancer Therapy: A Meta‐analysis of Clinical Trials

Cancer Medicine - United Kingdom
doi 10.1002/cam4.1970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Are All Cyclin-Dependent Kinases 4/6 Inhibitors Created Equal?

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2019English

Management of Adverse Events During Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitor-Based Treatment in Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2018English

Efficacy and Safety Profile of Xanthines in COPD: A Network Meta-Analysis

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Pharmacology
Pharmacology
2019English

TheIn vitroandIn vivoEffects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases

Cancer Research
Cancer ResearchOncology
2005English

Correction: Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials

PLoS ONE
Multidisciplinary
2016English

Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Cell Cycle and Cancer: Genetic Analysis of the Role of Cyclin-Dependent Kinases

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2005English

Therapeutic Effect of Palbociclib in Chondrosarcoma: Implication of Cyclin-Dependent Kinase 4 as a Potential Target

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy